BioPharma Credit plc
(the "Company")
TRANSACTION IN OWN SHARES
BioPharma Credit PLC announces that today it has purchased the following number of its ordinary shares of
Ordinary Shares: BPCR LN
Date of purchase: 2 May 2024
Number of ordinary shares purchased: 1,223,261
Lowest price per share:
Highest price per share:
Trading venue: London Stock Exchange
Ordinary Shares: BPCR LN
Date of purchase: 2 May 2024
Number of ordinary shares purchased: 500,000
Lowest price per share:
Highest price per share:
Trading venue: JPSI
Aggregate volume per date per trading venue: 1,723,261
Weighted average price per day per trading venue:
Following the above transaction, the Company holds 152,273,822 of its ordinary shares in treasury and has 1,221,658,245 ordinary shares in issue (excluding treasury shares). Therefore, the total number of voting rights in the Company is 1,221,658,245. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
BioPharma Credit plc
via Link Company Matters Limited
Company Secretary
+44 (0) 333 300 1950
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is
LEI: 213800AV55PYXAS7SY24
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.